Press Release

News Archive

Golden Ticket Sponsored by Celgene Corporation

Golden Ticket Sponsored by Celgene Corporation San Francisco, CA, August 24, 2018 - MBC BioLabs, the premier Bay Area life-science incubator, will present its Golden Ticket programs this year as well as future initiatives at MBC Biolabs through a sponsorship from Celgene. The Golden Ticket program is provided to promising, qualified entrepreneurs and offers priority admission or renewal, including rent [...]Read more

AMGEN and MBC BioLabs announce winners of the AMGEN Golden Ticket

AMGEN and MBC BioLabs announce winners of the AMGEN Golden Ticket Two Biotherapeutic Companies Receive Lab Space and Other Benefits at Bay Area Life Sciences Incubator THOUSAND OAKS, Calif. and SAN FRANCISCO (June 29, 2018) Amgen (NASDAQ:AMGN) and MBC BioLabs (formerly QB3@953) announced today that Delve Therapeutics and Mitokinin have won the Amgen Golden Ticket at MBC BioLabs. Each company receives [...]Read more

Nitto Partners with MBC BioLabs for a New San Carlos Life Science Startup Incubator

Nitto Partners with MBC BioLabs for a New San Carlos Life Science Startup Incubator Accelerate Innovations in Life Science Osaka, Japan and San Carlos, CA (May 1, 2018) Nitto Denko Corporation (Head Office: Osaka City, President: Hideo Takasaki), a global materials company, and MBC BioLabs (Location: San Carlos, California, General Manager: Douglas Crawford), a life science incubator in the San [...]Read more

ViewPoint Therapeutics Raises $35 Million in Series B Financing

ViewPoint Therapeutics Raises $35 Million in Series B FinancingProceeds will advance lead product candidate through clinical proof-of-concept studies in cataracts and presbyopia Series B led by The Rise Fund, a global impact fund SAN FRANCISCO, Calif., March 5, 2018 – ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development of crystallin stabilizers to prevent and treat cataracts and presbyopia, [...]Read more

AbbVie and MBC BioLabs Team Up to Support Life-Science Startups in the San Francisco Bay Area

AbbVie and MBC BioLabs Team Up to Support Life-Science Startups in the San Francisco Bay Area Read press release at CISION PR Newswire San Francisco, CA February 5, 2018 – AbbVie, a global biopharmaceutical company, and MBC BioLabs (formerly known as QB3@953), a life-science incubator, announced that they have teamed up to help support and mentor promising startups.  The partnership […]

Read more

QB3@953 Unites Life-Science Facility Under New MBC BioLabs Name

QB3@953 Unites Life-Science Facility Under New MBC BioLabs Name San Francisco, CA (February 5, 2018) – QB3@953 to become MBC BioLabs with the addition of a brand-new facility in San Carlos. QB3@953, an independent provider of innovative shared laboratory space located at 953 Indiana St. in San Francisco, was born out of the California Institute for Quantitative Biosciences, a three-campus […]

Read more

Japanese chemical firm Toray partners with QB3@953 to pursue breakthroughs in treatment of neurological diseases

Japanese chemical firm Toray partners with QB3@953 to pursue breakthroughs in treatment of neurological diseases San Francisco, CA, May 11, 2017 – QB3@953, the Bay Area’s premier life science incubator, welcomes Japan’s chemical giant Toray as its newest partner. The arrangement offers Toray the opportunity to nurture its budding pharmaceutical enterprise while bringing new expertise and trans-Pacific relationships to QB3@953’s […]

Read more

AMGEN and QB3@953 announce winners of the AMGEN GOLDEN TICKET

AMGEN AND QB3@953 ANNOUNCE WINNERS OF THE AMGEN GOLDEN TICKET San Francisco, CA, June 11, 2017 – Two Diagnostic Companies Will Receive Lab Space and Other Benefits at San Francisco Life Sciences Incubator Amgen (NASDAQ: AMGN) and QB3@953 today announced that Darmiyan and Enable Biosciences have won the Amgen Golden Ticket at QB3@953. Each company receives one year of lab […]

Read more

QB3@953 Companies Attract $1.36B In Capital

QB3@953 Companies Attract $1.36B In Capital San Francisco, CA, May 1, 2017 – QB3@953 proved definitively that its incubator facilities allow life science startups to progress at lightening speed, making a huge impact on the life-science ecosystem of the Bay Area. QB3@953 tenant and alumni companies are thriving. In the three short years since its founding, QB3@953 companies attracted $1.36Bn […]

Read more

QB3@953 facilitates strategic alliance between innovative start up member and a sponsor company

QB3@953 facilitates strategic alliance between innovative start up member and a sponsor company Telo Therapeutics enters into an Oncology-focused research collaboration with GSK San Francisco, CA, Feb 2, 2017 – QB3@953, the Bay Area’s premier life science incubator, today announced the collaboration between one of its member companies, Telo Therapeutics, and one of its sponsor companies, GlaxoSmithKline (GSK). Telo Therapeutics […]

Read more
Page 1 of 3123

Upcoming Event

  • San Carlos Open House

    15:00-17:00
    11/01/2018
    Please join us for an afternoon of celebration and posters from our community of companies at our new incubator.

Address

953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287
Map

Sign-Up for our Newsletter